COO vs. LMAT

In the year-to-date period, COO achieves a -12.01% return, which is significantly lower than LMAT's -0.33% return. Over the past 10 years, COO has underperformed LMAT with an annualized return of 6.03%, while LMAT has yielded a comparatively higher 27.94% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current COO Sharpe Ratio is -0.41, which is lower than the LMAT Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of COO and LMAT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

COO has not paid dividends to shareholders, while LMAT's dividend yield for the trailing twelve months is around 0.74%.

The maximum COO drawdown since its inception was -98.75%, which is greater than LMAT's maximum drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for COO and LMAT. For additional features, visit the drawdowns tool.

The Cooper Companies, Inc. (COO) has a higher volatility of 13.94% compared to LeMaitre Vascular, Inc. (LMAT) at 12.47%. This indicates that COO's price experiences larger fluctuations and is considered to be riskier than LMAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between The Cooper Companies, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.